ARID2 antibody (C-Term)
Quick Overview for ARID2 antibody (C-Term) (ABIN7467974)
Target
See all ARID2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Cross-Reactivity
- Human
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the C-terminus region of human ARID2. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: human ARID2-transfected 293T cells , HeLa nuclear , 293T , A431 , HeLa , HepG2 Validation: Orthogonal, Overexpression
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- ARID2 (AT Rich Interactive Domain 2 (ARID, RFX-Like) (ARID2))
-
Alternative Name
- AT-rich interaction domain 2
-
Background
-
Synonyms: AT-rich interaction domain 2 , BAF200 , CSS6 , p200
Background: ARID2 is a subunit of the PBAF chromatin-remodeling complex (see BAF180, MIM 606083), which facilitates ligand-dependent transcriptional activation by nuclear receptors (Yan et al., 2005 [PubMed 15985610]).[supplied by OMIM]
-
Molecular Weight
- 197 kDa
-
Gene ID
- 196528
-
UniProt
- Q68CP9
Target
-